Photometics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Photometics General Information

Description

Developer of an infrared light technology to treat cancer. The company's technology uses selective Photo-Apoptosis that uses infrared light to avoid the side effects of drugs, chemicals or ionizing radiation as well as offers ultrashort (femtosecond) pulses to avoid side effect of infrared light, enabling clinicians to get a safer technology as an alternative of ionizing radiation used for x-rays and other cancer therapies.

Contact Information

Website
www.photometics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 600 1st Avenue
  • Suite 442
  • Seattle, WA 98104
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 600 1st Avenue
  • Suite 442
  • Seattle, WA 98104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Photometics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 03-Jun-2022 Completed Out of Business
1. Early Stage VC (Series A) 01-Feb-2011 Completed Generating Revenue
To view Photometics’s complete valuation and funding history, request access »

Photometics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Photometics’s complete cap table history, request access »

Photometics Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Photometics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9909742-B2 Compact environmentally isolated cylindrical platform for optical components Inactive 24-Sep-2013
US-9702532-B1 Compact environmentally isolated cylindrical platform for optical components Active 24-Sep-2013
US-20170268755-A1 Compact environmentally isolated cylindrical platform for optical components Active 24-Sep-2013
US-20180149341-A1 Compact environmentally isolated cylindrical platform for optical components Inactive 24-Sep-2013
US-20110040295-A1 Cancer treatment using selective photo-apoptosis Inactive 28-Feb-2003 A61L2/0023
To view Photometics’s complete patent history, request access »

Ready to get started?

Request a free trial

Photometics FAQs

  • When was Photometics founded?

    Photometics was founded in 2009.

  • Where is Photometics headquartered?

    Photometics is headquartered in Seattle, WA.

  • What industry is Photometics in?

    Photometics’s primary industry is Biotechnology.

  • Is Photometics a private or public company?

    Photometics is a Private company.

  • What is Photometics’s current revenue?

    The current revenue for Photometics is .

  • How much funding has Photometics raised over time?

    Photometics has raised $1.74M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »